Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation

References

• Thompson, A. R. (1986). Structure, function and molecular defects of factor IX. Blood, 67, 565.
   PubMed Web of Science ®Google Scholar
• Pierce, G. F., Lusher, J. M., Brownstein, A. P. and Goldsmith, J. C. et al. (1989). The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost and supply of therapy. JAMA, 261, 3434.
   PubMed Web of Science ®Google Scholar
• Palmer, T. D., Thompson, A. R. and Miller, A. D. (1989). Production of human factor IX in animals by genetically modified skin fibroblasts: Potential therapy for hemophilia B. Blood, 73, 438.
   PubMed Web of Science ®Google Scholar
• Scharfmann, R., Axelrod, J.H. and Verma, I. M. (1991). Long-term in vivo expression of retrovirus mediated gene transfer in mouse fibroblasts implants. Proc. Natl. Acad. Sci. (USA), 88, 4626.
   Google Scholar
• Yao, S. N., Wilson, J. M., Nabel, E. G. and Kurachi, S. et al. (1991). Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B. Proc. Natl. Acad. Sci. (USA), 88, 8101.
   Google Scholar
• Gerrard, A. J., Hudson, D. L., Brownler, G. G. and Watt, F. M. (1993). Towards gene therapy for hemophilia B using primary human keratinocytes. Nature Genetics, 3, 180.
   PubMed Web of Science ®Google Scholar
• Dai, Y., Roman, M., Naviaus, R. K. and Verma, I. M. (1992). Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. (USA), 89, 10892.
   Google Scholar
• Yao, S. N. and Kurachi, K. (1992). Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc. Natl. Acad. Sci. (USA), 89, 3357.
   Google Scholar
• Kay, M. A., Rothenberg, S., Landen, C. N. and Bellinger, D. A. et al. (1993). In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science, 262, 117.
   PubMed Web of Science ®Google Scholar
• Smith, T. A. G., Mehaffey, M. G., Kayda, D. B. and Saunders, J. M. et al. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genetics, 5, 397.
   PubMed Web of Science ®Google Scholar
• Lozier, J. N., Thompson, A. R., Hu, P.-C. and Read, M. et al. (1994). Efficient transfection of primary cells in a canine hemophilia B model using adenovirus-polylysine-DNA complexes. Human Gene Therapy, 5, 313.
   PubMed Web of Science ®Google Scholar
• Dai, Y., Schwarz, E. M., Gu, D. and Zhang, W. W. et al. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor DC gene: tolerization of factor IX and vector antigens allows for longterm expression. Proc. Natl. Acad. Sci. USA, 92, 1401.
   Google Scholar
• Matthews, K. E., Dev, S. B., Toneguzzo, F. and Keating, A. (1995). Electroporation for gene therapy. In: Methods in Molecular Biology. Vol. 48 Animal Cell Electroporation Protocols. Eds. Nickoloff, J. A. and Totowa, NJ, Humana Press Inc., p. 273.
   Google Scholar
• Potter, H. (1988). Electroporation in Biology: Methods, Applications, and Instrumentation. Anal. Biochem., 174, 361.
   PubMed Web of Science ®Google Scholar
• Toneguzzo, F., Hayday, A. and Keating, A. (1986). Electric field mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells. Mol Cell Biol, 6, 703.
   PubMed Web of Science ®Google Scholar
• Toneguzzo, F. and Keating, A. (1986). Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field -mediated DNA transfer. Proc. Natl. Acad. Sci. USA, 83, 3496.
   Google Scholar
• Keating, A., Horsfall, W., Hawley, R. and Toneguzzo, F. (1990). Effect of different promoters on expression of genes introduced into hematopoietic and marrow stromal cells by electroporation. Exp Hematol., 18, 99.
   PubMed Web of Science ®Google Scholar
• Keating, A., Guinn, B. A., Laraya, P. and Wang, X. H. (1996). Human marrow stromal cells electrotransfected with human factor IX (FIX) cDNA engraft in scid mouse marrow and transcribe human FIX. Exp. Hematol., 24, 1056(abstract).
   Web of Science ®Google Scholar
• Keating, A., Just-Mitchell, K., Toor, P. and Klein, M. et al. (1986). Passaged human marrow stromal cells: a unique cell population. Exp Hematol., 14(6), 426.
   Web of Science ®Google Scholar
• Anklesaria, P., Kase, K., Glowacki, J. and Holland, C. A. et al. (1987). Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery form total body irradiation. Proc. Natl. Acad. Sci. (USA), 84, 7681.
   Google Scholar
• Wu, D. D. and Keating, A. (1991). Engraftment of donor derived bone marrow stromal cells. Exp Hematol, 19, 485.
   Web of Science ®Google Scholar
• Lazarus, H. M., Haynesworth, S. E., Gerson, S. L. and Rosenthal, N. S. et al. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transpl., 16, 557.
   PubMed Web of Science ®Google Scholar
• Keating, A. and Toor, P. (1990). Human long-term bone marrow culture. In: Methods in Molecular Biology, vol. 5. Eds. Pollard, J. W. and Walker, J. M. The Humana Press, Inc. Clifton, NJ, p. 331.
   Google Scholar
• Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular cloning: a laboratory manual. 2nd ed., Cold Spring Harbour Laboratory Press.
   Google Scholar
• Feinberg, A. P. and Vogelstein, B. (1983). Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem., 132, 6.
   PubMed Web of Science ®Google Scholar
• Branch, D. R. and Mills, G. B. (1995). pp60c-src expression is induced by activation of normal human T lymphocytes. J. Immunol., 154, 3678.
   PubMed Web of Science ®Google Scholar
• Borowski, M., Furie, B. C. and Furie, B. (1986). Distribution of gamma-carboxyglutamic acid residues in partially carboxylated human prothrombins. J. Biol. Chem., 261, 1624.
   PubMed Web of Science ®Google Scholar
• McKee, P. A. (1983). Hemostasis and disorders of blood coagulation. In: The Metabolic Basis of Inherited Diseases, 5th ed. Eds. Stanbury, J. B., Wyngaarden, J. B., Frederickson, D. S., Goldstein, J. L. and Brown M. S., McGraw-Hill, New York, p. 1531.
   Google Scholar
• Morgan, G. E., Rowley, G., Green, P. M., Chisholm, M. and Giannelli, F. (1997). Further evidence for the importance of an androgen response element in the factor IX promoter. Br. J. Haem., 98, 79.
   PubMed Web of Science ®Google Scholar
• Kurachi, S., Hitomi, Y., Furukawa, M. and Kurachi, K. (1995). Role of intron 1 in expression of the human factor IX gene. J. Biol. Chem., 270, 5276.
   PubMed Web of Science ®Google Scholar
• Gilkeson, G. S., Pritchard, A. J. and Pisetsky, D. S. (1991). Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Clin Immunol. Immunopathol., 59, 288.
   PubMedGoogle Scholar
• Jiao, S., Williams, P., Berg, R. K. and Hodgeman, B. A. et al. (1992). Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther., 3, 21.
   PubMed Web of Science ®Google Scholar
• St. Louis, D. and Verma, I. (1988). An alternative approach to somatic cell therapy. Proc. Natl. Acad. Sci. USA, 85, 3150.
   Google Scholar
• Palmer, T. D., Rosman, G. J., Osborne, W. R. A. and Miller, A. D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduce genes. Proc. Natl. Acad. Sci. USA, 88, 1330.
   Google Scholar
• Challita, P. M. and Kohn, D. B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA, 91, 2567.
   Google Scholar